Aller au contenu principal
Accès ouvert déclaré 2025 article

The role of personalized precision medicine in enhancing diagnostic accuracy and clinical outcomes

3Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : my. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Personalized precision medicine is a unique approach that tailors treatment and prevention strategies according to an individual’s specific needs. This individualized approach has revolutionized the management of conditions such as cancer, inflammatory diseases, and inherited diseases and has emerged from our understanding of normal and diseased states, leading to the development of new biomedical assays for more precise disease classification and diagnosis. Furthermore, this approach identifies individuals at risk for developing a disease, thereby allowing personalized treatment. These strategies consider the variability in genetic predisposition, environment, and lifestyle among patients. Hence, cancer treatment has shifted from empirical methods to a more focused and tailored strategy that provides the right patient with the right medicine at the right time. Patients’ genetic material can be analyzed using information derived from clinically validated assays. Patients who can gain benefits are stratified and identified to ensure that they are treated, whereas others who are unlikely to benefit can receive alternative treatments. One example is stem cell therapy, which has emerged as a form of personalized medication for conditions secondary to surgeries, trauma, age-related conditions, complications from medications, autoimmune diseases, and numerous other problems. Autologous or allogeneic stem cells such as mesenchymal stem cells and induced pluripotent stem cells can be used for direct tissue treatment in a rapid, personalized, and efficient manner. This approach of engineering cells and altering their functions before clinical use offers numerous benefits that are essential for personal health.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
The role of personalized precision medicine in enhancing diagnostic accuracy and clinical outcomes
Date Crossref
01/04/2025
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Genetic Associations and EpidemiologyCancer Genomics and DiagnosticsGenomics and Rare Diseases

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.